c.moreau
Submits third-party assay reports on material purchased directly. Based in Ghent.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.55%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043625 | L-Glutathione (reduced) | WXT | WXT-2605-B5720 | Janoshik | 2026-Q3 | 97.87 | 6.10 | 90.7 | Buyer-sourced | 1 | FAIL |
| AX-2026-042214 | Enclomiphene citrate | TFC | TFC-2605-H9340 | Medutest | 2026-Q2 | 99.65 | 4.25 | 99.6 | Buyer-sourced | 1 | FAIL |
| AX-2026-041699 | Ipamorelin | QSC | QSC-2602-W8434 | Janoshik | 2026-Q1 | 99.93 | 6.00 | 95.4 | Buyer-sourced | 0 | PASS |
| AX-2026-042095 | Retatrutide | TFC | TFC-2508-V6510 | Janoshik | 2026-Q1 | 98.43 | 3.49 | 95.9 | Buyer-sourced | 0 | PASS |
| AX-2025-020844 | BPC-157 | SGN | SGN-2507-F1655 | Janoshik | 2025-Q3 | 98.60 | 4.61 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019648 | PEG-MGF | Homopeptide | HOMO-2412-B2201 | Kestrel | 2025-Q2 | 97.86 | 5.46 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005480 | Ipamorelin | WXT | WXT-2410-J4996 | Janoshik | 2024-Q4 | 98.55 | 3.05 | 96.2 | Buyer-sourced | 1 | FAIL |
| AX-2024-005561 | Selank | BCH | BCH-2407-M7005 | PeptideMeter | 2024-Q3 | 98.98 | 6.69 | 104.1 | Buyer-sourced | 1 | FAIL |
| AX-2024-005266 | LL-37 | SSA | SSA-2403-V7183 | PeptideMeter | 2024-Q2 | 97.89 | 2.12 | — | Laboratory-retained | 0 | PASS |